The GLP is committed to full transparency. Download and review our 2019 Annual Report

Lawsuits against Monsanto alleging glyphosate-cancer connection face court scrutiny

roundup monsanto bayer merger
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

U.S. District Judge Vince Chhabria will spend a week hearing from experts to help decide whether there is valid scientific evidence to support the lawsuits’ claim that exposure to Roundup can cause non-Hodgkin’s lymphoma.

Chhabria is presiding over more than 300 lawsuits against Monsanto Co. by cancer victims and their families who say the company long knew about Roundup’s cancer risk but failed to warn them.

The plaintiffs must first persuade Chhabria, however, that he should allow their epidemiologists and other doctors to testify to a jury that Roundup can cause cancer. Many regulators have rejected the link, and Monsanto vehemently denies it and says hundreds of studies have found glyphosate — Roundup’s active ingredient — is safe.

Related article:  Séralini pseudoscience syndicate: Lessons learned from decade-long assault on biotechnology orchestrated by French geneticist

Chhabria will not determine if the cancer connection exists, but whether the claim has been tested, reviewed and published and is widely accepted in the scientific community.

“It’s game over for the plaintiffs if they can’t get over this hurdle,” said David Levine, an expert in federal court procedure at the University of California, Hastings College of the Law.

Read full, original post: Judge weighs science behind Monsanto Roundup cancer claim

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend